Copy
View this email in your browser
December 16, 2022 

This issue of Research Bulletin is the last of the calendar year. We hope you continue to find the curated content to be informative and insightful. This content will be back in your inbox in January 2023. In the meantime, we wish you a very happy holiday season!

In This Issue

  • Submit your FRTC application by 5pm today!
  • Register for a UCI NIH Boot Camp Information Session.
  • Read a report about U.S. doctorate recipients.
  • NIH is looking to simplify its review criteria. See how you can submit your feedback.
  • Browse four NIH funding opportunities and a UCOP seed grant for cancer research.

Announcements

Deadline Today: Faculty Research, Travel, and Computing (FRTC) Competition

Today is the last day to submit your application for FY 2022–2023 FRTC funding. Faculty who have a primary appointment in BioSci can submit proposals requesting support for research, travel, and computer hardware or software. Apply here by 5 PM PT. Full competition details are available on the application page. We expect awards to be announced in January 2023.

UCI NIH Boot Camp 2023: Register for Information Sessions

The School of Medicine (SOM) has announced a call for applications to the 2023 UCI NIH Boot Camp. This premier program is open to UCI faculty, across all schools, appointment types, and ranks. This will be the 7th year of the program, which allows our faculty the best opportunity for success in their first NIH grant applications.

Boot camp mentees work with experienced NIH-funded faculty mentors and are provided support throughout the grant writing process. Since 2017, 87 mentees from the College of Health Sciences and the Schools of Biological Sciences, Engineering, Physical Sciences, Social Ecology and Social Sciences have participated in the program. Numerous boot camp mentees have been awarded R01 and other grants, with additional proposals in the review pipeline.

Faculty who have not yet served as a PI on an NIH R01 grant (or equivalent) interested in participating as a mentee and experienced faculty with NIH funding interested in participating as a mentor are encouraged to attend one of the info sessions below. SOM will outline the program for the first 20 minutes, with Q&A to follow immediately.

NIH Boot Camp details and the application can be found at 2023 UCI NIH Boot Camp Website.

Questions can be directed to the SOM Research Development Unit (RDU) at somrd@hs.uci.edu.

Doctorate Recipients from U.S. Universities: 2021 Report

This report summarizes trends in U.S. doctoral education by using data from the 2021 Survey of Earned Doctorates, an annual census of research doctorate recipients from U.S. universities. Important trends in this population are highlighted in this report, including the representation of women, minorities, and temporary visa holders; fields that are attracting graduate students; time to complete doctoral degree; employment opportunities after graduation; and educational pathways to the doctorate. A special section focuses on the impact of the COVID-19 pandemic on doctorate recipients’ graduate experiences and post-graduation plans.

Getting Grants

NIH Looking to Simplify Review Criteria

NIH is proposing to simplify its review criteria for research project proposals (i.e., the “R” mechanisms). To gather public opinion on its revised framework, NIH has issued a Request for Information (RFI); you can submit your feedback here. The RFI portal is open until March 10, 2023.

The proposed framework reorganizes the current five core criteria (Significance, Investigators, Innovation, Approach, Environment) into three factors (Importance of the Research, Rigor and Feasibility, Expertise and Resources). You can find more information about the proposed changes here.

Funding Opportunities

NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA), issued by the National Institute of Allergy and Infectious Diseases (NIAID), invites applications for investigator-initiated Resource-Related Research Projects (R24). The proposed resource must provide a significant benefit to currently funded high priority projects in need of further coordination and support in the areas specified. Under rare circumstances, this mechanism may be used to support development of a new resource to the broader scientific community of the NIAID. It is anticipated that the request for resource support through the R24 activity code will occur on an infrequent basis and only in circumstances where other mechanisms of support from the NIAID are not appropriate.

The proposed resources should be relevant to the scientific areas of the NIAID mission including the biology, pathogenesis, and host response to microbes, including HIV; the mechanisms of normal immune function and immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, asthma, and transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat infectious, immune-mediated, and allergic diseases.

Next deadlines: January 25, 2023; May 25, 2023

NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) announces the renewal of the NIH Research Evaluation and Commercialization Hub (REACH) program, established to facilitate and accelerate the translation of academic biomedical discoveries into products that improve patient care and public health. Through this program, NIH will provide the qualifying institutions with the funds to seed the creation of academic entrepreneurship Hubs. Hubs will be responsible for providing innovators with both the initial investment and resources to support the proof-of-concept work and the mentorship in product development and commercialization needed to develop high priority technologies within the NIH’s mission. Funded Hubs are intended to work as a consortium to enable: (1) the infrastructure for identifying the most promising technologies, (2) funding for product definition studies (e.g. feasibility studies, prototype development, proof-of-concept studies) provided to individual researchers, (3) access to resources and expertise in areas required for early stage technology development (including scientific, regulatory, reimbursement, business, legal, and project management), and (4) skills development and hands-on experience in entrepreneurship. Establishing public-private partnerships and providing additional non-federal funds will be critical for success.

Deadline: February 9, 2023

NIDDK Investigator Award to Support Mentoring of Early Career Researchers from Diverse Backgrounds (K26 - Independent Clinical Trial Not Allowed)

The purpose of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Investigator Award to Support Mentoring of Early Career Researchers from Diverse Backgrounds is to provide protected effort and resources to established, NIDDK-funded, mentors to provide high quality mentoring to graduate students and postdoctoral fellows from diverse backgrounds, including those from underrepresented groups (see, e.g., Notice of NIH’s Interest in Diversity). Program Directors/Principals Investigators (PD/PIs) (mentors) must be conducting research that falls within the missions of the NIDDK and such research programs should serve as the framework around which mentoring activities are constructed. PD/PIs/applicants must have a demonstrable track record of mentoring early career researchers from diverse backgrounds, including those from underrepresented groups.

This Funding Opportunity Announcement (FOA) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.

Deadline: February 28, 2023

NIH Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. The overall goal is to support the development of highly innovative technologies capable of maximizing or otherwise interrogating the quality and utility of biological samples used for downstream analyses. This FOA will support the development of tools, devices, instrumentation, and associated methods to preserve or protect sample integrity, or establish verification criteria for quality assessment/quality control and handling under diverse conditions. These technologies are expected to accelerate and/or enhance research in cancer biology, early detection and screening, clinical diagnosis, treatment, or epidemiology, or address issues associated with cancer health disparities, by reducing preanalytical variations that affect biospecimen sample quality. Projects proposing the application of existing technologies where the novelty resides in the biological or clinical target/question being pursued are not responsive to this solicitation and will not be reviewed.

Next deadline: March 1, 2023

UCOP Cancer Research Coordinating Committee (CRCC) Faculty Seed Grant

CRCC Faculty Seed Grants support meritorious research spanning all areas from basic research to applied clinical and community-based research in any field relevant to cancer. The CRCC encourages proposals from faculty whose research addresses cancer disparities or whose backgrounds are not well-represented in cancer research. The CRCC provides one-year seed grants to faculty on the 10 UC campuses, with the expectation that the most promising endeavors will become competitive for larger, long-term grants from other funding sources.

Awards are made in two categories: New Assistant Professor (NAP) and Regular (REG), as described below. The maximum award amount for the 2023-24 award year will be $75,000. The award term is October 1, 2023 through September 30, 2024. Applicant principal investigators selected for a Faculty Seed Grant in 2023 will have an opportunity to request a supplement of up to $10,000 concurrent with their award year to support trainees from underrepresented communities or whose research addresses the impact of cancer in underserved communities. 

LOI deadline: January 24, 2023
Full proposal deadline: April 13, 2023

Submit Your Ideas

Help us to generate information for the Research Bulletin.

Submit details about seminars and other research-related events on campus here. 

Submit funding opportunity announcements here.

If the Research Bulletin was forwarded to you and you’d like to subscribe, sign up here

If you’re a faculty member, postdoc, graduate student, or other researcher in the School of Biological Sciences and would like help with a grant submission, please email bio-research@uci.edu.

To let the Pre-Award team know of your planned proposal submission, please fill out this form at least four weeks before the deadline.


Research Administration and Development
Supporting the grant infrastructure that fuels biological discoveries
www.research.bio.uci.edu

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.